VBLT - VBL Therapeutics EPS misses by $0.02 misses on revenue March, 25 2021 07:10 AM Vascular Biogenics Ltd. VBL Therapeutics (VBLT): FY GAAP EPS of -$0.55 misses by $0.02.Revenue of $0.92M (+64.3% Y/Y) misses by $0.02M.Press Release For further details see: VBL Therapeutics EPS misses by $0.02, misses on revenue